Exploring Synergies Health Systems and Sustainability TB/HIV collaboration Alasdair Reid UNAIDS Pretoria International Multistakeholder Consultation on.

Slides:



Advertisements
Similar presentations
The Novartis Malaria Initiative Der Weg zur Eliminierung von Malaria Silvio Gabriel, BASAID April 2012.
Advertisements

UNDP RBA Workshop on MDG-Based National Development Strategies Module 4: Health Strategies UN Millennium Project February 27-March 3, 2006.
1 TREATMENT AND PREVENTION SCALE-UP: THE SOUTH AFRICAN EXPERIENCE By Dr Moolman Team South Africa.
DOTS/ DOTS PLUS IMPLEMENTATION AND INTEGRATION Vaira Leimane State Centre of Tuberculosis and Lung Diseases of Latvia Paris, October, 28.
TB/HIV Research Priorities in Resource- Limited Settings Where we are now and some suggestions for where to go Paul Nunn February 2005.
February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.
No Goals at Half-time: What Next for the Millennium Development Goals? Goal 6: Combating HIV/AIDS, malaria and other diseases John Porter.
Our vision is a world free from TB. Our mission is to address the health, social and economic impact of the global TB epidemic amongst vulnerable and.
How Universal will Universal Access be in Europe by 2010? Eddy Beck Evaluation Department UNAIDS, Geneva
Unit 1. Introduction TB Infection Control Training for Managers at the National and Subnational Levels.
TB/HIV Integration What it entails Frank Lule, Eyerusalem Negussie, Reuben Granich, Haileyesus Getahun.
HIV and Tuberculosis interaction and integration Anthony D Harries The “Union”, Paris, France London School of Hygiene & Tropical Medicine, UK.
Collaborative TB/HIV activities, |1 | Collaborative TB/HIV activities 2012 Tables, Graphs & Maps Source: Global Tuberculosis Control Report 2013.
From DOTS to the Stop TB Strategy Building on Achievements for Future Planning Stop TB Partnership Symposium at the 37 th UNION World Conference on TB.
Involving all health care providers in collaborative TB/HIV activities Eva Nathanson PPM subgroup meeting Cairo, Egypt, 3-5 June 2008.
Country Update: Tuberculosis in Thailand
Turning the tide: Not without prisons! Promoting comprehensive national HIV responses.
Expert consultation on TB/HIV research priorities, February 2005 Mesdames et messieurs, soyez les bienvenus On behalf of the organizing committee.
Monitoring and Evaluation of VCT programs
TB/HIV: Global Progress in Implementation and Challenges Diane V. Havlir, MD University of California, San Francisco, CA Diane V. Havlir, MD University.
Washington D.C., USA, July 2012www.aids2012.org A National Program Manager’s Perspective on HIV/TB Integration Dr Owen Mugurungi Director – AIDS.
Scaling up Prevention of Mother to Child Transmission of HIV (PMTCT): What Will it Take to Eliminate MTCT? Jessica Rodrigues Presentation for UNICEF Written.
U. S. Senate Briefing World TB Day Celine Gounder, MD, ScM Center for TB Research, Johns Hopkins University Director for Delivery, CREATE On behalf of.
Annabel Baddeley Global TB Programme WHO, Geneva
National TB/ Leprosy Programme Manager
Accelerating TB/HIV activities in Zambia Alwyn Mwinga 2007 HIV Implementers Meeting 20 June 2007.
Tools for HIV/TB Integration and the Civil Society Experience Carol Nawina Nyirenda Executive Director Community Initiative for Tuberculosis, HIV/AIDS.
Challenge 4: Linking TB & HIV/AIDS Programs Kayt Erdahl, Project HOPE Rodrick Nalikungwi, Project HOPE Malawi December 18, 2008.
Isoniazid preventive therapy for people living with HIV: Public health challenges and implementation issues Peter Godfrey-Faussett UNAIDS (with thanks.
5 th DOTS Expansion Working Group Meeting, Paris, October 28, 2004 Tuberculosis and HIV - Future Directions Paul Nunn, Stop TB Dept., WHO, Geneva GLOBAL.
6 th Biannual Joint HIV Sector Review Meeting Nov 11-13,2014 Ministry of Health and Social Welfare Mwanaisha Nyamkara, NTLP Werner Maokola, NACP Nov 11,
TB/HIV COLLABORATION IN GHANA Dr. Nii Nortey Hanson – Nortey National TB Control Programme Accra.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
From Mekong to Bali: The scale up of TB/HIV collaborative activities in Asia- Pacific, August 8-9, 2009 Denpasar, Bali, Indonesia "TB/HIV Monitoring and.
The revised TB/HIV indicators and update on the process of harmonization Christian Gunneberg MO WHO The 14th Core Group Meeting of the TB/HIV Working Group.
Haileyesus Getahun Stop TB Department WHO Re-conceptualizing ICF and IPT: global progress to date 14 th Core Group Meeting of the TB/HIV Working Group,
Colleen Daniels Stop TB Department World Health Organisation TB, HIV and Drug Use The overview.
Collaborative TB/HIV Activities. Collaborative TB/HIV activities A.To establish the mechanisms for collaboration B.To decrease the burden of TB in PLWHA.
Integration of collaborative TB/HIV activities with harm reduction services Maryna Zelenskaya Ph D State service on HIV/AIDS and other socially diseases.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
Challenges of Intensified TB case finding among PLHIV : Kenyan experience Dr. J. Sitienei Ministry of Health Kenya.
Gap Analysis: Tuberculosis Care in Malawi Round 11 proposal to the Global Fund to Fight AIDS, Tuberculosis and Malaria Africa 3: Team Malawi Arianna, Babatunde,
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
TB infection control in the era of MDR and XDR TB Haileyesus Getahun Stop TB Department WHO/HQ.
TB-HIV Last updated: January 2017.
TB/ HIV CONTROL AND MANAGEMENT IN SOUTH AFRICA
Progress with intensified TB Case Finding in Nigeria
Progress in Implementing collaborative TB/HIV activities
TB/HIV surveillance : Who is going to get the job done?
TB-HIV Last updated: March 2018.
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
World Health Organization
TB Infection Control Actions needed at country level
Progress in Implementation of TB/HIV Collaborative activities
TB-HIV Last updated: November 2018.
Knowledge gaps in formulating TB Control Policies for Prisons
TB Infection Control Actions needed at country level
Tolerability of Isoniazid Preventive therapy Among HIV infected Cohort in Nigeria Folajinmi Oluwasina Strategic Information Unit AIDS Healthcare Foundation,
Enablers for nationwide expansion of collaborative TB/HIV activities
Screening and diagnosing TB in PLHIV: Challenges and ways forward
Integrating TB and HIV care services – Malawi Experiences
monitoring & evaluation THD Unit, Stop TB department WHO Geneva
Introduction to poster session and discussion
Presentation for Second Meeting of the Global TB/HIV Working Group
South Africa: From ProTest to Nationwide Implementation
From ProTEST to Nationwide Implementation
The STOP TB Strategy – 2009 VISION: A TB-free world
Collaborative TB/HIV activities 2011 Tables, Graphs & Maps
HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE
Presentation transcript:

Exploring Synergies Health Systems and Sustainability TB/HIV collaboration Alasdair Reid UNAIDS Pretoria International Multistakeholder Consultation on National AIDS Programmes Enhancing effectiveness, efficiency and social sustainability Nairobi 19/20 April 2012

Outline Epidemiology History Examples Conclusion

Estimated number of cases, 2010 Estimated number of deaths, million * (0.9–1.2 million) 8.8 million (8.5–9.2 million) ~ 650,000 out of 12 million (11-14 million) prevalent TB cases All forms of TB Multidrug- resistant TB HIV-associated TB 1.1 million (1.0–1.2 million) 350,000 (320,000–390,000) Source: WHO Global Tuberculosis Control Report 2011 ( ) * Excluding deaths attributed to HIV/TB Global Burden of TB

Epidemiology HIV & TB TB incidence in PLHIV about 5-10% per year 1 in 4 deaths in PLHIV are due to TB HIV prevalence in TB patients as high as 80%

Incidence of TB per 100,000 population, 2010 Prevalence of HIV among new TB patients, 2010

History of TB and HIV collaboration ProTEST studies in Zambia, Malawi and South Africa 2004 WHO Interim Policy on Collaborative TB/HIV activities – rapid uptake by partners (GFATM, PEPFAR) and over 170 countries by end UNGASS political declaration includes collaborative TB/HIV activities for PLHIV 2011 HLM political declaration sets target of halving TB deaths in PLHIV by WHO Policy on Collaborative TB/HIV activities (GRADE)

WHO Policy on collaborative TB/HIV activities A.Establish and strengthen the mechanisms for delivering integrated TB and HIV services B.Reduce the burden of TB in people living with HIV and initiate early antiretroviral therapy (the Three I’s for HIV/TB) C.Reduce the burden of HIV in patients with presumptive and diagnosed TB –

The updated 12 points policy package B. Decrease the burden of TB in PLHIV through earlier ART and Three Is for HIV/TB 5. Intensify TB case finding and ensure quality TB treatment 6. Introduce TB prevention with IPT and ART 7. Infection control for TB in health care and congregate settings ensured A. Establish the mechanisms for integrated TB and HIV services 1. Set up or strengthen a TB/HIV coordinating body effective at all levels 2. Conduct HIV and TB surveillance among TB and HIV patients respectively 3. Carry out joint TB/HIV planning 4. Conduct monitoring and evaluation C. Decrease the burden of HIV in patients with presumptive and diagnosed TB 8. Provide HIV testing & counselling to patients with presumptive and diagnosed TB 9. Introduce HIV preventive methods patients with presumptive and diagnosed TB 10. Provide CPT for TB patients living with HIV 11. Ensure HIV prevention, treatment & care for TB patients living with HIV 12. Provide Antiretroviral therapy to TB patients living with HIV

A. Establish and strengthen the mechanisms for delivering integrated TB and HIV services A.1. Set up and strengthen a coordinating body functional at all levels A.2. Determine HIV prevalence among TB patients and TB prevalence among PLHIV A.3. Carry out joint TB/HIV planning to integrate the delivery of TB and HIV services – One stop shop – Joint capacity building and engaging NGOs and communities A.4. Monitor and evaluate collaborative TB/HIV activities

One stop shop Large loss to follow up with cross referral even if this is 2 different clinics in the same building Patients referred from TB to HIV clinic for ART took almost 3 times longer (116 days vs 41 days) to start ART compared to those diagnosed with TB in the HIV clinic. – Lawn BMC Infectious Disease 2011 Increase in notification of smear-negative pulmonary and extrapulmonary TB in PLHIV and of treatment success rates thru integration in Lesotho and South Africa – Bygrave H IAS 2010, Brown C CROI 2011 Integrate with other health programmes such as maternal and child health, harm reduction services and prison health services

Joint capacity building & engaging NGOs & communities Hasina Subedar

Joint capacity building & engaging NGOs & communities Trained home-based care and community health-care workers as well as nongovernmental organizations have been successful in providing integrated TB and HIV services in various countries – WHO TB/HIV policy Community-based TB and HIV care services are cost effective – WHO TB/HIV policy

B. Reduce the burden of TB in people living with HIV and initiate early antiretroviral therapy B.1. Intensify TB case-finding and ensure high quality TB treatment B.2. Initiate TB prevention with Isoniazid preventive therapy and early antiretroviral therapy B.3. Ensure control of TB Infection in health-care facilities and congregate settings

TB screening in PLHIV Up to 30% of PLHIV initiating ART have undiagnosed culture confirmed TB. Simple symptom screening very cost effective but misses (10-20%) asymptomatic culture positive TB in new ART patients Laboratory TB screening is highly cost-effective even with 2 GeneXpert tests for every new ART patient – Andrews JR, AIDS 2012 IPT and infection control cost effective – WHO TB/HIV policy

C. Reduce the burden of HIV in patients with presumptive and diagnosed TB C.1. Provide HIV testing and counselling to patients with presumptive and diagnosed TB C.2. Provide HIV prevention interventions for patients with presumptive and diagnosed TB C.3. Provide co-trimoxazole preventive therapy for TB patients living with HIV C.4. Ensure HIV prevention interventions, treatment and care for TB patients living with HIV C.5. Provide antiretroviral therapy for TB patients living with HIV

HIV testing for TB patients National HIV prevalence in TB patients varies significantly (6% -77%) Routine voluntary HIV testing of TB patients in India is effective and cost-effective despite low HIV prevalence in TB patients (2.9-9%) – Uhler LM, PLoS ONE 2010 HIV testing of presumptive TB cases who turn out not to have active TB disease also yields high HIV-positive results – WHO TB/HIV policy High acceptance (74%) of HIV testing among contacts of TB patients in Thailand and a higher (13.8%) HIV prevalence rate among contacts of HIV-positive TB cases as compared with contacts of HIV negative TB cases (2.5%) – WHO TB/HIV policy Opportunity to initiate early ART to HIV positive TB patients and reduce morbidity and mortality (up to 95%) and recurrent TB

South African HCT campaign April June million pre-test counselled 13 million (88%) HIV tested 2 million (16%) tested positive for HIV 8 million (54%) client screened for TB 1 million (13%) referred for TB investigation Over 300,000 PLHIV started on IPT 1.4 million people on ART

Global implementation of key TB/HIV activities (2003 – 2010)

Conclusions Evidence based programme integration can increase efficiency and effectiveness and respond better to client needs Rapidly taken to scale Integration itself is low cost Good evidence of efficiency and effectiveness of the individual elements of the collaborative policy but no studies examining cost-effectiveness of full package of integration - do we need them?

Acknowledgements IAS H. Getahun D. Sculier T. Hiatt H. Subeda

THANK YOU